Viridian Therapeutics, Inc. (VRDN)
NASDAQ: VRDN · Real-Time Price · USD
22.44
+0.61 (2.79%)
At close: Sep 16, 2026, 4:00 PM EDT
22.44
0.00 (0.00%)
After-hours: Sep 16, 2026, 4:10 PM EDT
Viridian Therapeutics Market Cap
Viridian Therapeutics has a market cap or net worth of $2.54 billion as of September 16, 2026. Its market cap has increased by 72.86% in one year.
Market Cap
2.54B
Enterprise Value
1.81B
1-Year Change
72.86%
Ranking
Category
Stock Price
$22.44
ChartMarket Cap Chart
Since June 18, 2014, Viridian Therapeutics's market cap has increased from $34.70M to $2.54B, an increase of 7,226.45%. That is a compound annual growth rate of 41.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 2.54B | -14.41% |
| Dec 31, 2025 | 2.97B | 95.60% |
| Dec 31, 2024 | 1.52B | 32.59% |
| Dec 29, 2023 | 1.15B | -2.59% |
| Dec 30, 2022 | 1.18B | 173.74% |
| Dec 31, 2021 | 429.50M | 567.96% |
| Dec 31, 2020 | 64.30M | 320.26% |
| Dec 31, 2019 | 15.30M | -83.62% |
| Dec 31, 2018 | 93.40M | -59.86% |
| Dec 29, 2017 | 232.70M | 6,363.89% |
| Dec 30, 2016 | 3.60M | -55.00% |
| Dec 31, 2015 | 8.00M | -16.67% |
| Dec 31, 2014 | 9.60M | -72.33% |
| Jun 18, 2014 | 34.70M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pharvaris | 2.67B |
| Disc Medicine | 2.58B |
| Nurix Therapeutics | 2.58B |
| Mineralys Therapeutics | 2.56B |
| NewAmsterdam Pharma Company | 2.53B |
| Precigen | 2.51B |
| Harmony Biosciences Holdings | 2.46B |
| Vera Therapeutics | 2.43B |